Todays announcement builds upon our historic Most Favored Nations drug pricing deals goal of democratizing access to weight-loss medication, which has been out of reach for so many in need, CMS Administrator Mehmet Oz, MD, said in a statement in December 2025
Originally developed for type II diabetes, it is now widely used to help patients lose weight when combined with diet and exercise
Specifically, Retatrutide is studied as a triple receptor agonist targeting glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
How to Prepare for Your First Shot of Ozempic Preparing for your first Ozempic injection involves more than just using the pen
Imaging 14 , e012174 (2021)
Federal courts are being asked to weigh in as consumers challenge the meaning of GLP-1-related claims on products